Treatment for Tooth Infection
Primary Treatment: Surgery First, Antibiotics Only When Indicated
Surgical intervention—including root canal therapy, tooth extraction, or incision and drainage—is the cornerstone of treatment for tooth infections and must be performed immediately; antibiotics are adjuncts only and should never replace definitive source control. 1, 2, 3
Surgical Options Based on Tooth Restorability
- Root canal therapy is preferred when the tooth has adequate crown structure remaining, is periodontally sound, and this is the first endodontic intervention 2
- Extraction is indicated when the tooth is non-restorable due to extensive caries, severe crown destruction, structural compromise, severe periodontal disease, or previous endodontic treatment failure 2
- Incision and drainage should be performed for all accessible abscesses to establish drainage and remove purulent material 1, 2
When to Add Antibiotics to Surgical Treatment
Clear Indications for Antibiotics (Add to Surgery)
- Systemic signs present: fever, tachycardia, tachypnea, elevated white blood cell count, or malaise 1, 2
- Spreading infection: cellulitis, diffuse facial swelling, or rapidly progressing infection beyond the localized tooth area 1, 2
- Medically compromised patients: immunosuppressed individuals, diabetics, or those with significant comorbidities 1, 2
- Extension into deep spaces: infection spreading into cervicofacial tissues, mandibular bone (osteomyelitis), or fascial planes 1, 3
- Airway compromise risk: swelling threatening airway patency requires hospitalization and IV antibiotics 1
When Antibiotics Are NOT Indicated
- Localized abscess without systemic symptoms when adequate surgical drainage can be achieved—antibiotics provide no additional benefit 1, 2
- Irreversible pulpitis without systemic involvement—source control via dental treatment alone is sufficient 1
- Acute apical periodontitis without systemic signs—manage surgically without antibiotics 1
Evidence note: Multiple systematic reviews demonstrate no statistically significant reduction in pain or swelling when antibiotics are added to proper surgical treatment in localized infections without systemic signs 1, 2
First-Line Oral Antibiotic Regimen (When Indicated)
For Penicillin-Tolerant Patients
- Amoxicillin 500 mg orally three times daily for 5 days (or 875 mg twice daily) 1, 2
- Alternative: Penicillin V (phenoxymethylpenicillin) 500 mg four times daily for 5–7 days 1, 4
For Penicillin-Allergic Patients
- Clindamycin 300–450 mg orally three times daily for 5 days—preferred alternative with excellent anaerobic coverage 1, 2, 4
Second-Line Options (Treatment Failures or Specific Indications)
Amoxicillin-clavulanate (Augmentin) 875 mg/125 mg twice daily is reserved for specific situations only 1:
- Recent antibiotic use within the past month (increases risk of beta-lactamase-producing organisms) 1
- Prior treatment failure with amoxicillin 1
- Moderate to severe infection with systemic toxicity 1
- Age > 65 years 1
- Immunocompromised or diabetic patients 1
Do not use amoxicillin-clavulanate as routine first-line therapy—its broader spectrum does not improve outcomes in uncomplicated cases 1
Severe Infections Requiring Hospitalization and IV Antibiotics
Indications for Hospital Admission
- Risk of airway compromise due to facial/neck swelling 1
- Systemic toxicity with altered mental status or hemodynamic instability 1
- Deep tissue involvement or extension into multiple fascial spaces 1, 5
Recommended IV Regimens
- Ampicillin-sulbactam 1.5–3.0 g IV every 6 hours—preferred single-agent therapy providing comprehensive polymicrobial coverage 1
- Alternative: Ceftriaxone 1 g IV every 24 hours PLUS metronidazole 500 mg IV every 8 hours 1
- For immunocompromised patients: Consider piperacillin-tazobactam or a carbapenem for broader coverage 1
- For penicillin-allergic patients: Clindamycin 600–900 mg IV every 6–8 hours 1
Duration and Transition
- Total antibiotic duration: 5–10 days based on clinical response, with most cases not exceeding 7 days when adequate source control is achieved 1
- Transition to oral therapy (e.g., clindamycin 300–450 mg three times daily) once clinical improvement is evident 1
Antibiotics to Avoid
- Fluoroquinolones: Inadequate coverage of typical odontogenic pathogens 1
- Macrolides (erythromycin, azithromycin): High resistance rates (>40%) among oral streptococci—not recommended as first-line 1
- Metronidazole alone: Does not cover facultative and aerobic gram-positive cocci; may only be added to amoxicillin for documented treatment failures 1, 4
Special Populations
Diabetic Patients
- Lower threshold for antibiotic initiation due to higher risk of severe infection and complications 1
- Optimize glycemic control—hyperglycemia impairs immune function and delays healing 1
- Consider broader empiric coverage for severe infections 1
Pediatric Patients (Including Infants)
- High-dose amoxicillin 80–90 mg/kg/day divided 3–4 times daily for children < 2 years, especially after recent antibiotic exposure 1
- Extraction is preferred over pulpectomy for primary teeth with severe infection or near natural exfoliation 1
- Clinical improvement expected within 48–72 hours after surgical drainage plus antibiotics 1
- Schedule pediatric dental follow-up within 2–3 days 1
Renal Impairment
- CrCl 10–30 mL/min: Amoxicillin-clavulanate 875 mg/125 mg once daily 1
- CrCl < 10 mL/min: Amoxicillin-clavulanate 875 mg/125 mg once daily 1
- Hemodialysis: Administer dose after each dialysis session 1
Treatment Algorithm
Assess severity and extent of infection:
Perform definitive surgical intervention immediately:
Add antibiotics only if:
Select appropriate antibiotic:
Reassess at 48–72 hours:
Common Pitfalls to Avoid
- Never prescribe antibiotics without surgical intervention—this is ineffective and promotes antibiotic resistance 1, 2
- Do not use amoxicillin-clavulanate routinely as first-line—reserve for specific indications only 1
- Do not extend antibiotic duration beyond 5–7 days in uncomplicated cases with adequate source control—longer courses do not improve outcomes 1
- Do not use metronidazole as monotherapy—it lacks coverage of aerobic gram-positive cocci 1, 4